Press communication
Lund, Sweden, August 17, 2023
This is a translation of the Swedish press release published 2023-08-17
Neola Medical AB (the “Company”) has appointed ABG Sundal Collier (“ABGSC”) as liquidity provider for the Company’s shares listed on Nasdaq Stockholm. The commitment takes place within the framework of Nasdaq Stockholm’s rules on liquidity providers. ABGSC undertakes to continuously during the opening hours quote prices for Neola Medical’s share in accordance with the at all time prevailing minimum requirements for liquidity providers set out by Nasdaq Stockholm aiming at improving the liquidity of the share and reducing the spread. ABGSC’s assignment commences on August 21, 2023.
For further information, contact
Hanna Sjöström, CEO Neola Medical, e-mail: hanna.sjostrom@neolamedical.com
Christian Gyllenberg, CFO Neola Medical, e-mail: christian.gyllenberg@neolamedical.com
Read the entire translation of the Swedish press release here: Press communication
Read the entire press release (in Swedish) here: Press release